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Implantation of an Andrastent XL in
an adult with advanced chronic heart failure
due to coarctation of the aorta
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A b s t r a c t
We report the case of a 49 year-old-man with congenital coarctation of the aorta (CoA), admitted in a critical clinical condi-
tion due to advanced secondary cardiomyopathy and chronic heart failure. An Andrastent XL was implanted successfully in
the CoA. The procedure resulted in an almost completely resolved CoA and prompt clinical improvement in the patient.
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INTRODUCTION
Patients with congenital coarctation of the aorta (CoA) usual-
ly die due to left ventricular failure caused by a sudden col-
lapse of myocardial function [1]. Surgical treatment of CoA
has been performed for many years with good results, altho-
ugh the risk of surgery is much higher in adults than in chil-
dren [2]. Transcatheter stent implantation seems to be a va-
luable alternative to surgical treatment.
We describe the case of a 49 year-old man with severe
CoA, whose clinical condition at hospital admission was criti-
cal, with signs of overt and very advanced heart failure (HF).
The patient had not been previously treated, as he had refu-
sed to give consent to any invasive procedure. The use of an
expandable aortic stent effectively widened the narrowed
aorta, and proved to be a life-saving procedure in this clinical
setting.
CASE REPORT
A 49 year-old man was admitted to the intensive care unit
(ICU) of our centre with end-stage chronic HF caused by se-
condary cardiomyopathy due to the presence of CoA. Four
years previously, he had been diagnosed with congenital CoA.
Computer tomography performed at that time revealed tight
CoA in a typical location (Fig. 1) with a short section of hypo-
plastic vessel below the stenosis. The patient had been offe-
red two therapeutic options — a cardiac surgical procedure
or a transcatheter expansion of CoA using an expandable
aortic stent. The patient was then in NYHA class II and his left
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ventricular ejection fraction was good. Unfortunately, at this
time he would not give his consent to any form of invasive
treatment.
Since then, the patient’s clinical condition had gradually
deteriorated. From February 2011 onwards, the patient was
repeatedly hospitalised due to rapidly increasing symptoms
of HF, but he still refused invasive treatment. In July 2011, he
was referred to our centre in a critical condition.
On admission, the patient presented with NYHA class
IV, with evidence of active sepsis and deep purulent ulcera-
tions of the left lower limb, associated with massive ascites
and pleural effusions. His left ventricular ejection fraction was
only 15%. Physical examination revealed typical signs of end-
stage chronic HF, very severe dyspnoea and lack of femoral
pulses. Oxygen saturation was 88% and the patient was ad-
ministered oxygen via a face mask. At this stage, the patient
finally gave his consent to invasive treatment, in the form either
of a cardiac surgical procedure or an aortic stent implanta-
tion. Shortly after his admission to the ICU, he suffered sud-
den cardiac arrest due to ventricular fibrillation. Resuscita-
tion procedures were successful and sinus rhythm was resto-
red after 20 min. However, the patient required artificial ven-
tilation with 100% oxygen and very high infusion doses of
adrenaline (0.5–0.8 mcg/kg/min) to provide satisfactory blood
pressure and efficient cardiac output.
Another three successfully treated incidents of cardiac
arrest occurred. Thoracic ultrasound revealed massive pleu-
ral effusions and 2,000 mL of clear fluid was drained from the
right pleural cavity, which resulted in a marked improvement
in oxygenation. It was decided that the only therapeutic option
in such a critical condition was a percutaneous stent implan-
tation into the CoA as a medical emergency.
The patient was transferred to the cath lab intubated,
artificially ventilated, and on a high-dose adrenaline infu-
sion. The time between the first incident of cardiac arrest
and the start of the procedure was only 2 h. Cardiac cathete-
risation was performed via the left femoral artery. The CoA
was crossed using a hydrophilic guidewire and multipurpo-
se catheter. The pressure measured in the ascending aorta
was 106/70 (82) mm Hg, while in the descending aorta it was
80/62 (69 mm Hg), meaning systolic gradient was 26 mm Hg.
The aortographic image revealed a tight CoA in a typical lo-
cation (1.5 cm below the left subclavian artery) and a short
hypoplastic section of the aorta below the stenosis with a dia-
meter of 7–8 mm. The diameter of the aorta was 20 mm
above the CoA, and 25 mm at the level of the diaphragm.
Extrastiff guidewire (0.035 ¥ 260 cm long) was inserted into
the ascending aorta. The short 6 F sheath was replaced with
a 12 F long Mullins sheath. An Andrastent 48 XL (Andramed
GmbH, Germany) was mounted on the balloon catheter Maxi
LD 16 mm ¥ 4 cm (Cordis Comp.). The proper location of
the stent was confirmed angiographically and the stent was
expanded (Fig. 2). The overall time of the procedure was
55 min, with the fluoroscopy lasting 4.5 min.
Immediately after the procedure, the systolic gradient
through the CoA had diminished to 4 mm Hg and a clear
pulse had appeared on the femoral arteries. A dramatic im-
provement in the patient’s general condition was also noted.
Catecholamine doses were gradually reduced. Over the sub-
sequent days of treatment in the ICU, the left pleural cavity
Figure 1. Computer tomography scan showing tight coarctation
of the aorta in the typical location
Figure 2. Control aortography (manual contrast injection) in
LAO view after stent implantation
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and the abdominal cavity were drained with resulting volu-
mes of 1,200 mL and 5,000 mL, respectively. The patient
was gradually weaned off the ventilator and was extubated
72 h after undergoing the procedure.
In his subsequent time in ICU, the patient presented very
high levels of procalcitonin and signs of sepsis. Blood cultures
revealed the presence of Meticillin-Susceptible Staphylococ-
cus Aureus. He was therefore given high-dose intravenous
penicillin, which yielded a gradual improvement. Heparin-
induced thrombocytopaenia was also suspected (due to the
presence of characteristic skin lesions and low platelet co-
unt). When this was definitely confirmed via laboratory tests,
low-molecular weight heparin was immediately converted to
subcutaneous fondaparinux (Arixtra, GlaxoSmithKline), with
a rapid resolution of skin lesions and an improvement in the
patient’s general condition. After 12 days of ICU treatment,
the patient was transferred to the general cardiology ward in
a good and stable condition. He remained in hospital for the
next nine days, mainly due to the need for surgical manage-
ment of a deep wound to the lower leg and the necessity of
taking high doses of intravenous antibiotics. Eventually, he
was discharged home after 21 days of treatment and curren-
tly remains in a NYHA II/III functional class.
DISCUSSION
In the natural history of CoA, the appearance of HF has two
distinct peaks. The first peak relates to about 5% of neonates
with CoA, and is often associated with the presence of ac-
companying heart defects. In most adult patients with conge-
nital CoA however, the heart defect usually remains asymp-
tomatic until the patient is in his or her thirties, with a second
peak therefore occurring only after the age of 40. This is usu-
ally associated with concomitant aortic stenosis, coronary ar-
tery disease or cardiomyopathy, which increases the existing
arterial hypertension [1].
Our previous studies, as well as multicentre studies by
other researchers, have shown very encouraging results of
stent implantation in CoA over both short- and long-term
observations [3, 4]. It is worth mentioning that in the reports
of interventional treatment of CoA, the procedures have al-
ways been performed by interventional cardiologists (not by
interventional radiologists, as proposed by the Polish health-
care payer).
In the presented case, we performed a procedure of aor-
tic stenting without balloon catheter predilatation, as previo-
usly proposed by Bulbul et al. [5]. This was because the extre-
mely serious condition of our patient before and during the
procedure meant that we needed to keep intervention time
to a minimum. This also reduced the possibility of stent migra-
tion. We applied a new type of cobalt-chromium balloon-
-expandable stent (namely Andrastent XL). We have found
this type of stent is very useful in widening congenital and
acquired stenoses of large vessels [6, 7].
We believe two important conclusions may be drawn
from this case report.
Firstly, that CoA should be treated as soon as a severe
form of this defect is established. Performing this procedure
a few years earlier would have avoided the disastrous conse-
quences of CoA.
Secondly, that it is never too late for this procedure, as
our patient had no other treatment option on admission to
our centre. Similar observations were made by Alcibar et al.
[8]. The fundamental mechanism that contributed to the
improvement following the procedure was a reduction of
afterload, when the obstruction of bloodflow (caused by the
CoA) was suddenly removed. These actions were associa-
ted with timely and effective procedures performed in the
setting of the intensive care unit by a multidisciplinary team,
with the profound involvement of anaesthesiologists and in-
tensivists.
We believe that transcatheter aortic stent implantation
in an adult with a severe CoA is the treatment of choice, ta-
king into account the critical symptoms of HF and the extre-
mely serious clinical condition of the patient.
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